Kurt Von Emster - Net Worth and Insider Trading
Kurt Von Emster Net Worth
The estimated net worth of Kurt Von Emster is at least $185 Million dollars as of 2025-04-26. Kurt Von Emster is the Director of Vaxcyte Inc and owns about 4,168,718 shares of Vaxcyte Inc (PCVX) stock worth over $137 Million. Kurt Von Emster is the Director of CRISPR Therapeutics AG and owns about 1,164,268 shares of CRISPR Therapeutics AG (CRSP) stock worth over $45 Million. Kurt Von Emster is also the Director of CymaBay Therapeutics Inc and owns about 108,406 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $4 Million. Besides these, Kurt Von Emster also holds Jasper Therapeutics Inc (JSPR) . Details can be seen in Kurt Von Emster's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kurt Von Emster has not made any transactions after 2023-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kurt Von Emster
Kurt Von Emster Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kurt Von Emster owns 6 companies in total, including Vaxcyte Inc (PCVX) , CymaBay Therapeutics Inc (CBAY) , and CRISPR Therapeutics AG (CRSP) among others .
Click here to see the complete history of Kurt Von Emster’s form 4 insider trades.
Insider Ownership Summary of Kurt Von Emster
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PCVX | Vaxcyte Inc | 2020-06-16 | director |
| CBAY | CymaBay Therapeutics Inc | 2023-09-29 | director |
| CRSP | CRISPR Therapeutics AG | 2018-12-18 | director |
 | | 2003-06-26 | 10 percent owner |
| | 2023-04-13 | director & 10 percent owner |
| | 2021-05-13 | director & 10 percent owner |
Kurt Von Emster Latest Holdings Summary
Kurt Von Emster currently owns a total of 4 stocks. Among these stocks, Kurt Von Emster owns 4,168,718 shares of Vaxcyte Inc (PCVX) as of June 16, 2020, with a value of $137 Million and a weighting of 74.05%. Kurt Von Emster owns 1,164,268 shares of CRISPR Therapeutics AG (CRSP) as of December 18, 2018, with a value of $45 Million and a weighting of 24.04%. Kurt Von Emster also owns 108,406 shares of CymaBay Therapeutics Inc (CBAY) as of September 29, 2023, with a value of $4 Million and a weighting of 1.9%. The other 1 stocks Jasper Therapeutics Inc (JSPR) have a combined weighting of 0.01% among all his current holdings.
Latest Holdings of Kurt Von Emster
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCVX | Vaxcyte Inc | 2020-06-16 | 4,168,718 | 32.92 | 137,234,197 |
| CRSP | CRISPR Therapeutics AG | 2018-12-18 | 1,164,268 | 38.27 | 44,556,536 |
| CBAY | CymaBay Therapeutics Inc | 2023-09-29 | 108,406 | 32.48 | 3,521,027 |
| JSPR | Jasper Therapeutics Inc | 2023-04-13 | 2,118 | 4.73 | 10,018 |
Holding Weightings of Kurt Von Emster
Kurt Von Emster Form 4 Trading Tracker
According to the SEC Form 4 filings, Kurt Von Emster has made a total of 1 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vaxcyte Inc is the acquisition of 12,500 shares on June 16, 2020, which cost Kurt Von Emster around $200,000.
According to the SEC Form 4 filings, Kurt Von Emster has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 72,934 shares on December 18, 2018, which brought Kurt Von Emster around $2 Million.
According to the SEC Form 4 filings, Kurt Von Emster has made a total of 1 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 15,921 shares on September 29, 2023, which brought Kurt Von Emster around $249,641.
More details on Kurt Von Emster's insider transactions can be found in the Insider Trading History of Kurt Von Emster table.Insider Trading History of Kurt Von Emster
- 1
Kurt Von Emster Trading Performance
GuruFocus tracks the stock performance after each of Kurt Von Emster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kurt Von Emster is 38.12%. GuruFocus also compares Kurt Von Emster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kurt Von Emster within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kurt Von Emster's insider trading performs compared to the benchmark.
Performance of Kurt Von Emster
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.19 | | | | | |
| Relative Return to S&P 500(%) | 9.19 | | | | | |
Kurt Von Emster Ownership Network
Ownership Network List of Kurt Von Emster
Ownership Network Relation of Kurt Von Emster
Kurt Von Emster Owned Company Details
What does Vaxcyte Inc do?
Who are the key executives at Vaxcyte Inc?
Kurt Von Emster is the director of Vaxcyte Inc. Other key executives at Vaxcyte Inc include SVP & Gen Counsel & Corp Sec Mikhail Eydelman , Chief Operating Officer Jim Wassil , and CFO & CBO Andrew Guggenhime .
Vaxcyte Inc (PCVX) Insider Trades Summary
Over the past 18 months, Kurt Von Emster made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 252,762 shares made by Grant Pickering , a net sale of 176,000 shares made by Andrew Guggenhime , and a net sale of 92,000 shares made by Jim Wassil .
In summary, during the past 3 months, insiders sold 34,000 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 34,000 shares. During the past 18 months, 644,309 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 644,309 shares.
Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vaxcyte Inc Insider Transactions
Kurt Von Emster Mailing Address
Above is the net worth, insider trading, and ownership report for Kurt Von Emster. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kurt Von Emster's mailing address is: San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
